The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Nanosuspensions: a promising drug delivery strategy
Abstract
Nanosuspensions have emerged as a promising strategy for the efficient delivery of hydrophobic drugs because of their versatile features and unique advantages. Techniques such as media milling and high-pressure homogenization have been used commercially for producing nanosuspensions. Recently, the engineering of nanosuspensions employing emulsions and microemulsions as templates has been addressed in the literature. The unique features of nanosuspensions have enabled their use in various dosage forms, including specialized delivery systems such as mucoadhesive hydrogels. Rapid strides have been made in the delivery of nanosuspensions by parenteral, peroral, ocular and pulmonary routes. Currently, efforts are being directed to extending their applications in site-specific drug delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Improving drug solubility for oral delivery using solid dispersions
Leuner, C. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00076-x · Cited by 2,574
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Serajuddin, A. T. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980403l · Cited by 1,648
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · cited 2×
“Nanoparticulate systems have shown tremendous potential in targeted drug delivery, especially to the brain (Schröeder et al 1998; Kreuter 2001).”
BackgroundDissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Hörter, D., & Dressman, J. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00130-7 · Cited by 819
Melt extrusion: from process to drug delivery technology
Breitenbach, J. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00061-9 · Cited by 742
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
Engineering liposomes for drug delivery: progress and problems
Gregoriadis, G. (1995) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)89017-4 · Cited by 626
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Müller, R., Jacobs, C., & Kayser, O. (2000) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14005-13 · Cited by 501
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Nanosuspensions for the formulation of poorly soluble drugs
Müller, R. H., & Peters, K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00311-6 · Cited by 480
Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration
Jacobs, C., & Müller, R. H. (2002) · Pharmaceutical Research · doi:10.1023/a:1014276917363 · Cited by 439
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract
Hörter, D., & Dressman, J. B. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00487-5 · Cited by 393
Mosharraf, M., & Nyström, C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00033-f · Cited by 386
Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen
Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., & Puglisi, G. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00057-x · Cited by 350
Bodmeier, R., & McGinity, J. W. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90073-7 · Cited by 330
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Aungst, B. J. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600821008 · Cited by 294
Liversidge, G. G., & Conzentino, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00148-c · Cited by 294
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
Benet, L. Z., Izumi, T., Zhang, Y., Silverman, J. A., & Wacher, V. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00034-6 · Cited by 292
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 285
Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability
Müller, R. H., & Jacobs, C. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00040-6 · Cited by 280
Liposomen: Möglichkeiten der Medikamentenfreisetzung
Allen, T. M. (1997) · Drugs · doi:10.2165/00003495-199700544-00004 · Cited by 279
Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier
Schroeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275
Overview of the lipid formulations of amphotericin B
Dupont, B. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.31 · Cited by 260
Constantinides, P. P., Scalart, J.-P., Lancaster, C., Marcello, J., Marks, G., Ellens, H., & Smith, P. L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018927402875 · Cited by 253
Ilium, L., Davis, S. S., Wilson, C. G., Thomas, N. W., Frier, M., & Hardy, J. G. (1982) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(82)90113-2 · Cited by 253
Blunk, T., Hochstrasser, D. F., Sanchez, J., Müller, B. W., & Müller, R. H. (1993) · ELECTROPHORESIS · doi:10.1002/elps.11501401214 · Cited by 251
Controlling liposome blood clearance by surface-grafted polymers
Woodle, M. C. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00136-1 · Cited by 242
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Peters, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.77 · Cited by 228
L�ck, M., Paulke, B.-R., Schr�der, W., Blunk, T., & M�ller, R. H. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19980305)39:3<478::aid-jbm19>3.0.co;2-6 · Cited by 225
Stability of lipid emulsions for drug delivery
Washington, C. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00116-o · Cited by 224
Gao, Z.-G., Choi, H.-G., Shin, H.-J., Park, K.-M., Lim, S.-J., Hwang, K.-J., & Kim, C.-K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00325-6 · Cited by 207
Excipient–Drug Interactions in Parenteral Formulations
Akers, M. J. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10154 · Cited by 202
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract
Ponchel, G., Montisci, M.-J., Dembri, A., Durrer, C., & Duchêne, D. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00098-2 · Cited by 191
Stealth® liposomes: from theory to product
Cˇeh, B., Winterhalter, M., Frederik, P. M., Vallner, J. J., & Lasic, D. D. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00456-5 · Cited by 191
Formulation of amphotericin B as nanosuspension for oral administration
Kayser, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00686-5 · Cited by 186
Sah, H. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01647-7 · Cited by 178
Tröster, S. D., Müller, U., & Kreuter, J. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90047-8 · Cited by 161
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 155
Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions
Trotta, M., Gallarate, M., Pattarino, F., & Morel, S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00432-1 · Cited by 152
Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery
Park, K.-M., & Kim, C. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00029-0 · Cited by 145
Juliano, R. L. (1988) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(88)90004-x · Cited by 142
Kusuhara, H., Suzuki, H., & Sugiyama, Y. (1998) · Journal of Pharmacy and Science · doi:10.1021/js970100b · Cited by 122
Preparation of griseofulvin nanoparticles from water-dilutable microemulsions
Trotta, M., Gallarate, M., Carlotti, M. E., & Morel, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00029-2 · Cited by 114
Places of emulsions in drug delivery
Nakano, M. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00096-x · Cited by 109
Papisov, M. I. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00135-x · Cited by 90
Bucolo, C., Maltese, A., Puglisi, G., & Pignatello, R. (2002) · Ophthalmic Research · doi:10.1159/000065608 · Cited by 88
Soma, C. E., Dubernet, C., BARRATT, G. M., Benita, S., & Couvreur, P. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00269-8 · Cited by 86
Schwendener, R. A., & Schott, H. N. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01209119 · Cited by 79
Kayser, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00640-2 · Cited by 71
Lück, M., Schröder, W., Harnisch, S., Thode, K., Blunk, T., Paulke, B., Kresse, M., & Müller, R. H. (1997) · Electrophoresis · doi:10.1002/elps.1150181538 · Cited by 39
Lück, M., Paulke, B. ‐., Schröder, W., Blunk, T., & Müller, R. H. (1998) · Journal of Biomedical Materials Research · Cited by 11
Kim, C., Hwang, Y.-Y., Chang, J. Y., et al. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00661-5 · Cited by 10
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Drug Solubility: Importance and Enhancement Techniques
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,004
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Metadata
- Authors
- Patravale, V. B., Date, A. A., & Kulkarni, R. M.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07-01
- Volume
- 56
- Issue
- 7
- Pages
- 827-840
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2059225643
- Cited by
- 904
- References
- 66
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.